ABOUT LETROKEY™- 5 TABLETS
LETROKEY™-5 contains Letrozole USP 5 mg, an aromatase inhibitor that reduces oestrogen production by blocking the aromatase enzyme. Letrozole is used in selected reproductive medicine protocols, including ovulation induction in certain cases. The 5 mg strength provides a measured oral dose and should be used according to the prescribed fertility treatment schedule.
What's Inside?
| Ingredient | Packing |
|---|---|
| Letrozole USP 5mg | 10 × 5 Blister |
Why Curo360 Lifesciences?
As a focused gynae pharma company, Curo360 brings together a carefully developed portfolio covering key areas of gynaecological care.
Gynaecology
at the Core
A clear focus across
women’s health segments.
Purposeful Product
Portfolio
Formulations around specific healthcare needs.
Coverage That
Goes Deeper
Key therapeutic areas
under one portfolio.
Evolving with
Healthcare Needs
A range that grows with changing requirements.










